Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Bullboard Posts
Comment by Stuatoron Sep 01, 2015 1:54am
209 Views
Post# 24067375

RE:GIBBON and OTHER's - ORGANIC Growth questions no answers

RE:GIBBON and OTHER's - ORGANIC Growth questions no answers
  • March Revenue exceeded $5,179,000 or $62,148,000 annualized run rate revenue.
  • July revenue is expected to exceed $9,700,000 or more than $116,400,000 in annualized run rate revenue.

Inorganic growth for the months:
Sleep Management contributed in one month: 42.5M/12Mths. = 3.5M 

Legacy Oxygen contributed in two months: 3.5M / 6Mths. =.58M 

5.179M + 4.08M = 9.259M
9.7M - 
9.259M = 0.441M /  8.969M = .0492 % in 4 months
14.76% annual organic growth 

This is really rough calculating considering it says that July is 
expected to exceed $9,700,000.  Another factor is that acquisition dates are generalised in my estimation considering I use months instead of days. These factors would have had a negative results on the organic # calculated.  Overall, I believe the organic growth is on par with PHM commentary of 25% or greater.

The real test will be to see how leveragable SM's huge customer database will be for PHM.  If they keep the >40% organic growth we've seen in the past...  this model is scary good.   



 
 
Bullboard Posts